Clinical Roundup Breast cancer screening tool predicts patient response to immunotherapies May 03, 2024Vol.50 No.18
Clinical Roundup One-tube test could expand cervical cancer screening, speed diagnosis May 03, 2024Vol.50 No.18
Clinical Roundup APC activation, CDK inactivation triggers “doubling” in cancer cell division May 03, 2024Vol.50 No.18
Drugs & Targets FDA issues additional draft guidance on eligibility criteria for cancer drug clinical trials May 03, 2024Vol.50 No.18
Drugs & Targets CHMP recommends approval of fruquintinib for previously-treated mCRC May 03, 2024Vol.50 No.18
Regulatory News ODAC unanimously upholds MRD as early endpoint across all settings in multiple myeloma April 26, 2024Vol.50 No.17By Jacquelyn Cobb
Conversation with The Cancer Letter Clearing the path for MRD as early endpoint in multiple myeloma April 26, 2024Vol.50 No.17By Jacquelyn Cobb
Health Equity Black patients with multiple myeloma aren’t getting autoHCT as often as others—and the disparity has widened April 26, 2024Vol.50 No.17By McKenzie Prillaman
